Ternium SA
NYSE:TX
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Ternium SA
Cash Equivalents
Ternium SA
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ternium SA
NYSE:TX
|
Cash Equivalents
$871.4m
|
CAGR 3-Years
80%
|
CAGR 5-Years
113%
|
CAGR 10-Years
N/A
|
|
Aperam SA
AEX:APAM
|
Cash Equivalents
€443m
|
CAGR 3-Years
7%
|
CAGR 5-Years
17%
|
CAGR 10-Years
8%
|
|
ArcelorMittal SA
AEX:MT
|
Cash Equivalents
$5.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
19%
|
CAGR 10-Years
1%
|
See Also
What is Ternium SA's Cash Equivalents?
Cash Equivalents
871.4m
USD
Based on the financial report for Dec 31, 2023, Ternium SA's Cash Equivalents amounts to 871.4m USD.
What is Ternium SA's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
113%
Over the last year, the Cash Equivalents growth was 71%. The average annual Cash Equivalents growth rates for Ternium SA have been 80% over the past three years , 113% over the past five years .